Lichter-Konecki U, Konecki D S, DiLella A G, Brayton K, Marvit J, Hahn T M, Trefz F K, Woo S L
Universitaets-Kinderklinic, Heidelberg, FRG.
Biochemistry. 1988 Apr 19;27(8):2881-5. doi: 10.1021/bi00408a032.
A novel restriction fragment length polymorphism in the phenylalanine hydroxylase (PAH) locus generated by the restriction endonuclease MspI was observed in a German phenylketonuria (PKU) patient. Molecular cloning and DNA sequence analyses revealed that the MspI polymorphism was created by a T to C transition in exon 9 of the human PAH gene, which also resulted in the conversion of a leucine codon to a proline codon. The effect of the amino acid substitution was investigated by creating a corresponding mutation in a full-length human PAH cDNA by site-directed mutagenesis followed by expression analysis in cultured mammalian cells. Results demonstrate that the mutation in the gene causes the synthesis of an unstable protein in the cell corresponding to a CRM- phenotype. Together with the other mutations recently reported in the PAH gene, the data support previous biochemical and clinical observations that PKU is a heterogeneous disorder at the gene level.
在一名德国苯丙酮尿症(PKU)患者中,观察到由限制性内切酶MspI产生的苯丙氨酸羟化酶(PAH)基因座中的一种新型限制性片段长度多态性。分子克隆和DNA序列分析表明,MspI多态性是由人类PAH基因第9外显子中的T到C转换产生的,这也导致亮氨酸密码子转换为脯氨酸密码子。通过定点诱变在全长人类PAH cDNA中产生相应突变,随后在培养的哺乳动物细胞中进行表达分析,研究了氨基酸取代的影响。结果表明,该基因突变导致细胞中合成一种不稳定的蛋白质,对应CRM-表型。与最近报道的PAH基因中的其他突变一起,这些数据支持了先前的生化和临床观察结果,即PKU在基因水平上是一种异质性疾病。